- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 21.07. | Alembic site slapped with FDA warning letter over patient consent concerns | ||
| 21.07. | Lilly, BMS aerospace partner Redwire opens new site in Indiana | ||
| 21.07. | Novartis CEO brushes off oral PCSK9 competition as Leqvio drives Q2 growth | ||
| 21.07. | Gilead, Merck's phase 3 data back first weekly HIV pill | ||
| 21.07. | Novo Nordisk files lawsuit accusing rival Eli Lilly of running 'false and misleading' GLP-1 ads | ||
| 21.07. | J&J's Tremfya remains on top in Q2 pharma ad spending league as overall outlay drops | ||
| 21.07. | The Oral GLP-1 Tracker: Lilly's Foundayo scripts tick up amid overall obesity market slowdown | ||
| 20.07. | Sanofi survey uncovers Type 1 diabetes misconceptions and screening gaps | ||
| 20.07. | J&J, Time link up to spotlight healthcare leadership with Healthcare Champion of the Year award | ||
| 20.07. | Samsung Biologics spreads wings with proposed $1.8B acquisition of Swiss CDMO PolyPeptide | ||
| 20.07. | Why Legend Biotech stock fell 10% despite record Carvykti sales | ||
| 17.07. | Novartis gains full FDA nod for Fabhalta in kidney disorder IgAN | ||
| 17.07. | Novo, Alvotech face continued FDA scrutiny at plants tied to recent FDA rejections | ||
| 17.07. | Fierce Pharma Asia-GSK, Merck ADCs' trial wins; AstraZeneca's $1.5B EGFR buy; Biotechs' new patent tricks | ||
| 17.07. | Foundation Medicine launches 'Quality First' initiative to stand out in cancer testing market | ||
| 16.07. | Huahai poaches quality chief from Hengrui amid FDA manufacturing citations | ||
| 16.07. | Vanda shifts Nereus marketing into high gear with Schumacher IndyCar sponsorship | ||
| 16.07. | Bipartisan Senate bill seeks to build vigilance around foreign companies making drugs in US | ||
| 16.07. | Merck scores at FDA as Lipfendra becomes world's first oral PCSK9 treatment | ||
| 16.07. | Otters, bears and Pharma Lions: inside Gilead's bronze-winning Cannes spot | ||
| 15.07. | Sanofi opens new chapters in Pfizer, Moderna mRNA patent litigation sagas | ||
| 15.07. | Novo gains head start on Lilly with European Commission approval of Wegovy pill | ||
| 15.07. | Merck touts Keytruda front-line win in endometrial cancer subtype, marking a PD-1 first | ||
| 15.07. | No patent protection for Stelara? No problem for J&J as Tremfya fills the void | ||
| 15.07. | Buzzy Veradermics shows its oral minoxidil can tackle female pattern hair loss, too |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.